Neurology

Many people living with focal onset seizures (FOS) fail to achieve seizure freedom, even after taking two or more anti-seizure..

During this symposium, leading international epileptologists discussed the key challenges and opportunities that currently exist within…

It’s time for Unwrapped 2025. Explore Neurology’s defining moments, our Word of the Year, and a challenging brain teaser.

Becker is a serious, progressive neuromuscular condition that is X-linked, affecting approximately one in 18,000 male births.1,2 It is…

Subcutaneous administration of natalizumab provides similar real-world effectiveness to intravenous administration, providing a convenient…

Epilepsy affects around 50 million people worldwide. Approximately 30% of them experience drug-resistant epilepsy (DRE), which…

Exploration of key data on chronic inflammatory demyelinating polyneuropathy (CIDP) presented at EHA 2025. Post-hoc analysis of the ADHERE…

Multiple sclerosis (MS) is a complex, lifelong neurological condition that presents with unpredictable symptoms, progressive disability…

Historically, sex-related differences have been underexplored in neurology. It is important to highlight the distinction between sex and…

Epilepsy is a serious and common neurological condition, characterised by recurring, unprovoked seizures, affecting approximately 25…

Neurosonology is a versatile, non-invasive diagnostic modality for evaluating cerebral circulatory disorders.1 It provides real-time…

In this patient-focused interview, EMJ spoke to Jean-Philippe Plançon, a patient with chronic inflammatory demyelinating….

It all began when my mother was diagnosed with Huntington’s disease. At the time, Huntington’s was a rare disease, and it still is by…

EMJ spoke with Christina Dalla, a pioneering researcher in neuropsychopharmacology and expert in sex differences in neuropsychiatric…

EMJ spoke with Lukas Rasulic to explore the latest advances in peripheral nerve repair, the integration of functional neurosurgery, and…

Neurocysticercosis, a parasitic brain infection caused by the larvae of Taenia solium that leads to cysts in the central nervous system…

For this article, EMJ conducted an interview with Ahmed Abdelmoity, Professor and Director, Division of Neurology, Children’s Mercy…

CAR T Therapy: The NEX-T Frontier in MS, a BMS non-promotional symposium at ECTRIMS 2024, presents a thought-provoking view on the potential role of CAR-T cell therapy in Multiple Sclerosis. 𝗙𝗼𝗿 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗣𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀𝗼𝗻𝗹𝘆. 𝗧𝗵𝗶𝘀 𝘀𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝘄𝗮𝘀 𝗼𝗿𝗴𝗮𝗻𝗶𝘀𝗲𝗱 𝗮𝗻𝗱 𝗳𝘂𝗻𝗱𝗲𝗱 𝗯𝘆 𝗕𝗿𝗶𝘀𝘁𝗼𝗹 𝗠𝘆𝗲𝗿𝘀 𝗦𝗾𝘂𝗶𝗯𝗯. 𝗕𝗠𝗦 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗮𝗻𝗱/𝗼𝗿 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗺𝗮𝘆 𝗯𝗲 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗲𝗱. (IMM-GB-2400302) | Date of Prep: June 2025

This symposium, ‘A case-based approach to navigating treatment switch in late-onset Pompe Disease (LOPD)’, was held at the 21st…

The landscape of neurology biomarkers has evolved significantly in recent years, affording new clinical insights that are helping to…

Generalised myasthenia gravis (gMG) is a rare and chronic IgG-mediated autoimmune neuromuscular disease that causes fluctuating and…